Sign In
Buy IDXX
$564.74
+4.01 (+0.715%)
At Close: Jun 04, 2026
Masimo (MASI) Reports Preliminary Q1 Results, Reiterates '22 View
01:47pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Masimo's (MASI) first-quarter 2022 results are likely to have been dampened by supply chain headwinds.
LHC Group's (LHCG) Deal With Optum to Boost Value-Based Care
03:31pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
LHC Group's (LHCG) deal with Optum is likely to enhance and extend value-based care to patients' homes.
Here's Why You Should Retain Nevro (NVRO) Stock For Now
03:12pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.
Veeva Systems (VEEV) Sees Wider Adoption of Its Development Cloud
02:17pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Veeva Development Cloud business.
Reasons to Retain Ecolab (ECL) Stock in Your Portfolio For Now
03:35pm, Tuesday, 29'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Ecolab (ECL) owing to its solid product portfolio.
Henry Schein (HSIC) Digital Dentistry Gains, Expands Globally
04:35pm, Monday, 28'th Mar 2022 Zacks Investment Research
Henry Schein (HSIC) witnesses strength in dental consumable merchandise sales in France, Germany, Austria, Belgium.
Here's Why You Should Retain Globus Medical (GMED) Stock Now
03:05pm, Friday, 25'th Mar 2022 Zacks Investment Research
Investors are optimistic about Globus Medical's (GMED) better-than-expected results and strength in the U.S. Spine business.
Phibro (PAHC) Rises 6.1% Since Q2 Earnings: What's Driving It?
03:03pm, Friday, 25'th Mar 2022 Zacks Investment Research
Investors are optimistic about Phibro's (PAHC) booming vaccine business and strong global presence.
National Vision (EYE) Hurt by Rising Costs, Vendor Dependency
01:44pm, Friday, 25'th Mar 2022 Zacks Investment Research
High dependence on a limited number of suppliers exposes National Vision (EYE) to supplier concentration risk.
Quest Diagnostics' (DGX) Volumes Aid, Price Pressure Stays
02:23pm, Thursday, 24'th Mar 2022 Zacks Investment Research
According to Quest Diagnostics (DGX), the delay of the 2022 PAMA cuts announced last year proved beneficial for the industry and Medicare beneficiaries.
Quest Diagnostics' (DGX) New Contract to Aid COVID-19 Research
02:00pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Quest Diagnostics' (DGX) COVID-19 serological tests, nationwide reach and data analytics capabilities will help assess COVID-19 vulnerability throughout the country.
Should iShares Russell MidCap Growth ETF (IWP) Be on Your Investing Radar?
10:20am, Thursday, 24'th Mar 2022 Zacks Investment Research
Style Box ETF report for IWP
Integra (IART) Debuts NeuraGen 3D for Peripheral Nerve Repair
01:28pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Integra's (IART) NeuraGen 3D will provide surgeons with access to the latest technology in peripheral nerve repair.
Encompass Health's (EHC) Nationwide Hospital Count Rises to 147
03:36pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Encompass Health (EHC) opens a 60-bed inpatient rehabilitation hospital in Illinois, sustaining its aim to offer enhanced rehabilitation services throughout the United States.
Reasons to Add Surmodics (SRDX) Stock to Your Portfolio
03:36pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Surmodics (SRDX) owing to its consistent efforts to boost R&D.
